We are live on
!
Find out more
GCM
Ghisallo Capital Management Portfolio holdings
AUM
$5.1B
1-Year Est. Return
39.13%
This Fund
S&P 500
This Quarter
Est. Return
+15.09%
1 Year Est. Return
+39.13%
3 Year Est. Return
+121.55%
5 Year Est. Return
+121.89%
10 Year Est. Return
–
AUM
$5.1B
AUM Growth
+$1.47B
(+40%)
Cap. Flow
+$410M
Cap. Flow
% of AUM
8.05%
Top 10 Holdings %
Top 10 Hldgs %
42.59%
Holding
458
New
148
Increased
12
Reduced
51
Closed
123
Avg Time Held
1.3
quarters
Top 10 Avg Time Held
0.3
quarters
Top 20 Avg Time Held
0.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$965M |
| 2 |
Digital Realty Trust
DLR
|
+$229M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$144M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$143M |
| 5 |
Super Micro Computer
SMCI
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$102M |
| 2 |
NVIDIA
NVDA
|
+$95.9M |
| 3 |
Microsoft
MSFT
|
+$92.5M |
| 4 |
GlobalFoundries
GFS
|
+$80.1M |
| 5 |
Medline Inc
MDLN
|
+$62.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 29.61% |
| 2 | Miscellaneous | 19.42% |
| 3 | Communication Services | 10.49% |
| 4 | Technology | 8.11% |
| 5 | Healthcare | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Lincoln International
LCLN
$856M
| $5.97M | 0.12% |
+250,000
| New | +$5.9M |
2026 Q2
0 quarters
|
|
102
National Healthcare Properties
NHP
$1.13B
| $5.86M | 0.12% |
+400,000
| New | +$5.6M |
2026 Q2
0 quarters
|
|
103
Kodiak Sciences
KOD
$5.76B
| $5.84M | 0.11% |
+150,000
| New | +$5.84M |
2026 Q2
0 quarters
|
|
|
EROC
104
ERock Inc
EROC
$557M
| $5.8M | 0.11% |
+400,000
| New | +$6.37M |
2026 Q2
0 quarters
|
|
105
Celcuity
CELC
$3.09B
| $5.75M | 0.11% |
+55,000
| New | +$6.35M |
2026 Q2
0 quarters
|
|
106
MP Materials
MP
$7.56B
| $5.6M | 0.11% |
100,000
| – | – |
2025 Q3
3 quarters
|
|
107
HawkEye 360 Inc
HAWK
$1.27B
| $5.56M | 0.11% |
+275,000
| New | +$7.6M |
2026 Q2
0 quarters
|
|
108
Scholar Rock
SRRK
$4.93B
| $5.5M | 0.11% |
+100,000
| New | +$4.83M |
2026 Q2
0 quarters
|
|
109
KPET Ultra Paceline Corp
KPET
$290M
| $5.49M | 0.11% |
+550,000
| New | +$5.51M |
2026 Q2
0 quarters
|
|
110
Vera Therapeutics
VERA
$1.93B
| $5.36M | 0.11% |
+125,000
| New | +$4.66M |
2026 Q2
0 quarters
|
|
111
Perimeter Acquisition Corp I
PMTR
$322M
| $5.21M | 0.1% |
500,000
| – | – |
2025 Q3
3 quarters
|
|
112
DELISTED
Electronic Arts
EA
| $5.17M | 0.1% |
25,200
| – | – |
2026 Q1
1 quarter
|
|
113
Applied Aerospace & Defense Inc
AADX
$1.8B
| $5.13M | 0.1% |
+225,000
| New | +$4.42M |
2026 Q2
0 quarters
|
|
114
Colombier Acquisition Corp III
CLBR
$406M
| $5.13M | 0.1% |
500,000
| – | – |
2026 Q1
1 quarter
|
|
115
Oxley Bridge Acquisition Ltd
OBA
| $5.12M | 0.1% |
500,000
| – | – |
2025 Q3
3 quarters
|
|
116
Summit Therapeutics
SMMT
$12.4B
| $5.1M | 0.1% |
+350,000
| New | +$6.21M |
2026 Q2
0 quarters
|
|
117
Irenic Acquisition Corp Unit
IACQU
| $5.08M | 0.1% |
+500,000
| New | +$5.03M |
2026 Q2
0 quarters
|
|
118
American Drive Acquisition Co
ADAC
$290M
| $5.01M | 0.1% |
500,000
| – | – |
2026 Q1
1 quarter
|
|
119
Ultragenyx Pharmaceutical
RARE
$1.47B
| $5.01M | 0.1% |
+150,000
| New | +$3.73M |
2026 Q2
0 quarters
|
|
120
EyePoint Inc
EYPT
$265M
| $5M | 0.1% |
+350,000
| New | +$4.68M |
2026 Q2
0 quarters
|
|
121
Launchpad Cadenza Acquisition Corp I
LPCV
| $4.99M | 0.1% |
500,000
| – | – |
2026 Q1
1 quarter
|
|
122
Hennessy Capital Investment Corp
HCIC
| $4.96M | 0.1% |
+500,000
| New | +$4.94M |
2026 Q2
0 quarters
|
|
123
QDRO Acquisition Corp
QADR
| $4.96M | 0.1% |
+500,000
| New | +$4.95M |
2026 Q2
0 quarters
|
|
124
Curbline Properties
CURB
$3.11B
| $4.93M | 0.1% |
+162,074
| New | +$4.63M |
2026 Q2
0 quarters
|
|
125
York Space Systems
YSS
$901M
| $4.92M | 0.1% |
200,000
-207,837
| -51% | -$6.45M |
2026 Q1
1 quarter
|
|
Similar funds
KACA
MRCP
CFO
YCM
BPCE
GIBU
ACM
BMO
Ghisallo Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Ghisallo Capital Management held 458 positions worth $5.1B, up 40% from $3.63B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Ghisallo Capital Management deployed $410M of net new capital in Q2 2026, opening 148 new positions and adding to 12 existing holdings. Its largest new stake was SpaceX: 5,678,145 shares worth $970M.
By sector, the portfolio is most concentrated in Industrials at 30% of assets, up from 17% a quarter earlier, followed by Miscellaneous and Communication Services.
On the sell side, the largest reduction was Medline Inc, an estimated $62.3M trimmed.
- Ghisallo Capital Management's largest Q2 2026 buy was SpaceX: 5,678,145 shares worth $970M.
- Ghisallo Capital Management added most to Diamondback Energy in Q2 2026, an estimated $29.1M increase.
- Ghisallo Capital Management's biggest Q2 2026 reduction was Medline Inc, cutting an estimated $62.3M.
- Ghisallo Capital Management fully exited Tesla in Q2 2026, selling an estimated $102M.
- Ghisallo Capital Management's ten largest holdings make up 43% of its $5.1B portfolio in Q2 2026.
- Ghisallo Capital Management opened 148 new positions and closed 123 in Q2 2026.
- Ghisallo Capital Management's portfolio value rose 40% quarter-over-quarter to $5.1B.
Based on Ghisallo Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.